Anti-diabetic treatment regulates pro-fibrotic TGF-? serum levels in type 2 diabetics.

Pscherer, Stefan; Freude, Thomas; Forst, Thomas; Nüssler, Andreas K.; Braun, Karl F.; Ehnert, Sabina

dc.contributor.author	Freude, Thomas
dc.contributor.author	Nüssler, Andreas
dc.contributor.author	Ehnert, Sabrina
dc.date.accessioned	2017-11-08T14:43:27Z
dc.date.available	2017-11-08T14:43:27Z
dc.date.issued	2013
dc.identifier.issn	1758-5996
dc.identifier.uri	http://hdl.handle.net/10900/78370
dc.language.iso	en	de_DE
dc.publisher	London : BioMed Central	de_DE
dc.relation.uri	http://dx.doi.org/10.1186/1758-5996-5-48	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Anti-diabetic treatment regulates pro-fibrotic TGF-? serum levels in type 2 diabetics.	de_DE
dc.type	Article	de_DE
utue.publikation.seiten	48	de_DE
utue.personen.roh	Pscherer, Stefan
utue.personen.roh	Freude, Thomas
utue.personen.roh	Forst, Thomas
utue.personen.roh	Nüssler, Andreas K.
utue.personen.roh	Braun, Karl F.
utue.personen.roh	Ehnert, Sabina
dcterms.isPartOf.ZSTitelID	Diabetology and Metabolic Syndrome	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	5	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE